Pentixapharm Holding AG Sets IPO Placement Price at EUR 5.10 per Share

Berlin and Würzburg, Germany, October 1, 2024 – Pentixapharm Holding AG has finalized its initial public offering (IPO) placement price at EUR 5.10 per share. During the bookbuilding phase, all 3.9 million offer shares were placed. This includes both domestic and international placements to institutional and private investors.

The total gross proceeds from the IPO amount to EUR 19.9 million, leading to a post-money market capitalization of EUR 126.5 million. Following the IPO, the anticipated free float will be 61.6%. The largest shareholder, Eckert Wagniskapital und Frühphasenfinanzierung GmbH, holds 34.5% post-transaction.

Trading is expected to begin on October 2, 2024, with listed shares under ticker symbol "PTP" on the Frankfurt Stock Exchange. The offer shares will commence trading on October 10, 2024, post regulatory approvals and capital increase registration.